v3.25.4
Document and Entity Information
 12 Months Ended
Dec. 31, 2025
shares
IFRS Statement Line items  
Document Type 20-F
Document Registration Statement false
Document Annual Report true
Document Period End Date Dec. 31, 2025
Current Fiscal Year End Date --12-31
Document Transition Report false
Document Shell Company Report false
Securities Act File Number 001-36622
Entity Registrant Name ProQR Therapeutics N.V.
Entity Incorporation, State or Country Code P7
Entity Address, Address Line One Zernikedreef 9
Entity Address, City or Town Leiden
Entity Address, Postal Zip Code 2333 CK
Entity Address, Country NL
Title of 12(b) Security Ordinary Shares, nominal value € 0.04 per share
Trading Symbol PRQR
Security Exchange Name NASDAQ
Entity Common Stock, Shares Outstanding 105,361,064
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Accelerated Filer
Entity Emerging Growth Company false
ICFR Auditor Attestation Flag true
Document Accounting Standard International Financial Reporting Standards
Entity Shell Company false
Document Fiscal Year Focus 2025
Document Fiscal Period Focus FY
Entity Central Index Key 0001612940
Amendment Flag false
Auditor Firm ID 1012
Auditor Name KPMG Accountants N.V.
Auditor Location Amstelveen, the Netherlands
Document Financial Statement Error Correction [Flag] false
Business Contact [Member]  
IFRS Statement Line items  
Entity Address, Address Line One Zernikedreef 9
Entity Address, City or Town Leiden
Entity Address, Postal Zip Code 2333 CK
City Area Code +31
Local Phone Number 88 166 7000
Contact Personnel Name Dennis Hom
Entity Address, Country NL
Contact Personnel Email Address ir@proqr.com